Overview

Acamprosate in the Treatment of Pathological Gambling

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see whether acamprosate (Campral) will curb the desire to gamble in people with pathological gambling disorder.
Phase:
Phase 4
Details
Lead Sponsor:
University of Iowa
Collaborators:
Forest Laboratories
University of Nebraska
Treatments:
Acamprosate